Celltrion Sees Little Threat From ‘Overheated’ Biosimilar Competition
Presenting Q2 Results, Korean Giant Questions Ability Of Smaller Players To Survive
Celltrion believes smaller biosimilars players will struggle to compete with larger outfits • Source: Shutterstock 
